Clinical assessment in juvenile dermatomyositis

Autoimmunity

Volumn 39, Issue 3, 2006, Pages 197-203

  Ravelli, Angelo ^a   Ruperto, Nicolino ^a   Trail, Lucia ^a   Felici, Enrico ^a   Sala, Elena ^a   Martini, Alberto ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

Assessment; Core set of outcome measures; Definition of improvement; Disease activity; Disease damage; Juvenile dermatomyositis

Indexed keywords

CREATINE KINASE;

CAPILLAROSCOPY; CHILD; CLINICAL FEATURE; DAILY LIFE ACTIVITY; DERMATOMYOSITIS; DISEASE ACTIVITY; ELECTROMYOGRAPHY; ENZYME ACTIVITY; HUMAN; LABORATORY DIAGNOSIS; MUSCLE BIOPSY; MUSCLE STRENGTH; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT MONITORING; PROGNOSIS; QUALITY OF LIFE; RATING SCALE; REVIEW; STANDARDIZATION; VALIDATION PROCESS;

DERMATOMYOSITIS; HUMANS; MUSCLES; OUTCOME ASSESSMENT (HEALTH CARE); QUALITY OF LIFE;

EID: 33745085520     PISSN: 08916934     EISSN: 1607842X     Source Type: Journal    
DOI: 10.1080/08916930600622553     Document Type: Review

References (66)

1. Compeyrot-Lacassagne, S and Feldman, BM. (2005) Inflammatory myopathies in children Pediatr Clin North Am, 52, pp. 493-520.
2. Wedderburn, LR and Li, CK. (2004) Paediatric idiopathic inflammatory muscle disease Best Pract Res Clin Rheumatol, 18, pp. 345-358.
3. Cassidy, JT and Petty, RE.(2001) Juvenile dermatomyositis. In Textbook of pediatric rheumatology4th ed. (pp. 465-504). Philadelphis: WB Saunders.
4. Kim, B and Kaistha, SD and Rouse, BT. (2005) Viruses and autoimmunity Autoimmunity, 38, pp. 559-565.
5. Molina, V and Shoenfeld, Y. (2005) Infection, vaccines and other environmental triggers of autoimmunity Autoimmunity, 38, pp. 235-245.
6. Zandman-Goddard, G and Shoenfeld, Y. (2005) Infections and SLE Autoimmunity, 38, pp. 473-485.
7. Kendall, FP and McCreary, EK and Provance, PG. (1993) Muscles: Testing and function 4th ed. Baltimore: Williams and Wilkins.
8. Hicks, J and Wesley, R and Koziol, D and et al. (2000) Validation of manual muscle testing in the assessment of juvenile dermatomyositis Arthritis Rheum, 43(Suppl.), pp. S194.
9. Escolar, DM and Henricson, EK and Mayhew, J and et al. (2001) Clinical evaluator reliability for quantitative and manual muscle testing measures of strength in children Muscle Nerve, 24, pp. 787-793.
10. Hicks, J and Wesley, R and Koziol, D and et al. (2001) Consensus and economic advantages in use of abbreviated manual muscle testing in the assessment of idiopathic inflammatory myopathies (abstract) Arthritis Rheum, 44(Suppl.), pp. S352.
11. Hicks, J and Wesley, R and Koziol, D and et al. (2000) Preliminary validation of abbreviated manual muscle testing in the assessment of juvenile dermatomyositis Arthritis Rheum, 43(Suppl.), pp. S195.
12. Rider, LG. (2002) Idiopathic inflammatory myopathies Rheum Dis Clin North Am, 28, pp. 1-41.
13. Ramanan, AV and Feldman, BM. (2005) The role of muscle enzymes in JDM Pediatr Rheumatol Online J, 3, pp. 1-4.
14. Villalba, L and Hicks, JE and Adams, EM and et al. (1998) Treatment of refractory myositis: A randomized crossover study of two new cytotoxic regimens Arthritis Rheum, 41, pp. 392-399.
15. Oddis, CV and Medsger, TA, Jr. (1988) Relationship between serum creatine kinase level and corticosteroid therapy in polymyositis-dermatomyositis J Rheumatol, 15, pp. 807-811.
16. Guzman, J and Petty, RE and Malleson, PN. (1994) Monitoring disease activity in juvenile dermatomyositis: The role of von Willebrand factor and muscle enzymes J Rheumatol, 21, pp. 739-743.
17. Montecucco, C and Ravelli, A and Caporali, R and Viola, S and De Gennaro, F and Albani, S and Martini, A. (1990) Autoantibodies in juvenile dermatomyositis Clin Exp Rheumatol, 8, pp. 193-196.
18. Muro, Y. (2005) Antinuclear antibodies Autoimmunity, 38, pp. 3-9.
19. Zampieri, S and Ghirardello, A and Iaccarino, L and Tarricone, E and Gambari, PF and Doria, A. (2005) Anti-Jo1 antibodies Autoimmunity, 38, pp. 73-78.
20. Migliorini, P and Baldini, C and Rocchi, V and Bombardieri, S. (2005) Anti-Sm and anti-RNP antibodies Autoimmunity, 38, pp. 47-54.
21. Ghirardello, A and Zampieri, S and Iaccarino, L and Tarricone, E and Gambari, PF and Doria, A. (2005) Anti-Mi2 antibodies Autoimmunity, 38, pp. 79-83.
22. Lovell, DJ and Lindsley, CB and Rennebohm, RM and et al. (1999) Development of validated disease activity and damage indices for the juvenile idiopathic inflammatory myopathies. II. The Childhood Myositis Assessment Scale (CMAS): A quantitative tool for the evaluation of muscle function Arthritis Rheum, 42, pp. 2213-2219.
23. Huber, AM and Feldman, BM and Rennebohm, RM and et al. (2004) Validation and clinical significance of the Childhood Myositis Assessment Scale for assessment of muscle function in the juvenile idiopathic inflammatory myopathies Arthritis Rheum, 50, pp. 1595-1603.
24. Rennebohm, RM and Jones, K and Huber, AM et al. (2004) Normal scores for nine maneuvers of the Childhood Myositis Assessment Scale Arthritis Rheum, 51, pp. 365-370.
25. Singh, G and Athreya, BH and Fries, JF and Goldsmith, DP. (1994) Measurement of health status in children with juvenile rheumatoid arthritis Arthritis Rheum, 37, pp. 1761-1769.
26. Feldman, BM and Ayling-Campos, A and Luy, L and et al. (1995) Measuring disability in juvenile dermatomyositis: Validity of the childhood health assessment questionnaire J Rheumatol, 22, pp. 326-331.
27. Huber, AM and Hicks, JE and Lachenbruch, PA and et al. (2001) Validation of the childhood health assessment questionnaire in the juvenile idiopathic myopathies J Rheumatol, 28, pp. 1106-1111. Juvenile Dermatomyositis Disease Activity Collaborative Study Group
28. Ruperto, N and Ravelli, A and Pistorio, A and et al. (2001) Cross-cultural adaptation and psychometric evaluation of the childhood health assessment questionnaire (CHAQ) and the child health questionnaire (CHQ) in 32 countries. Review of the general methodology Clin Exp Rheumatol, 19(4 Suppl. 23), pp. S1-S9.
29. Bode, RK and Klein-Gitelman, MS and Miller, ML and Lechman, TS and Pachman, LM. (2003) Disease activity score for children with juvenile dermatomyositis: Reliability and validity evidence Arthritis Rheum, 49(1), pp. 7-15. Feb 15
30. Isenberg, DA and Allen, E and Farewell, V and et al. 2004 International consensus outcome measures for patients with idiopathic inflammatory myopathies. Development and initial validation of myositis activity and damage indices in patients with adult onset disease Rheumatology, 43, pp. 49-54.
31. Pilkington, C. (2004) Clinical assessment in juvenile idiopathic inflammatory myopathies and the development of disease activity and damage tools Curr Opin Rheumatol, 16, pp. 673-677.
32. Rider, LG and Feldman, BM and Perez, MD and et al. (1997) Development of validated disease activity and damage indices for the juvenile idiopathic inflammatory myopathies: I. Physician, parent, and patient global assessments Arthritis Rheum, 40, pp. 1976-1983. Juvenile Dermatomyositis Disease Activity Collaborative Study Group
33. Park, JH and Olsen, NJ. (2001) Utility of magnetic resonance imaging in the evaluation of patients with inflammatory myopathies Curr Rheumatol Rep, 3, pp. 334-345.
34. Eisenstein, DM and O'Gorman, MRG and Pachman, LM. (1997) Correlations between change in disease activity and changes in peripheral blood lymphocyte subsets in patients with juvenile dermatomyositis J Rheumatol, 24, pp. 1830-1832.
35. Adams, EM and Chow, CK and Premkumar, A and et al. (1995) The idiopathic inflammatory myopathies: Spectrum of MR imaging findings Radiographics, 15, pp. 563-574.
36. Fraser, DD and Frank, JA and Dalakas, M and et al. (1991) Magnetic resonance imaging in the idiopathic inflammatory myopathies J Rheumatol, 18, pp. 1693-1700.
37. Kimball, AB and Summers, RM and Turner, M and et al. (2000) Magnetic resonance imaging detection of occult skin and subcutaneous abnormalities in juvenile dermatomyositis. Implications for diagnosis and therapy Arthritis Rheum, 43, pp. 1866-1873.
38. Hernandez, RJ and Keim, DR and Sullivan, DB and et al. (1990) Magnetic resonance imaging appearance of the muscles in childhood dermatomyositis J Pediatr, 117, pp. 546-550.
39. Schweitzer, ME and Fort, J. (1995) Cost-effectiveness of MR imaging in evaluating polymyositis AJR Am J Roentgenol, 165, pp. 1469-1471.
40. Maillard, SM and Jones, R and Owens, C and et al. (2004) Quantitative assessment of MRI T2 relaxation time of thigh muscles in juvenile dermatomyositis Rheumatology, 43, pp. 603-608.
41. Reimers, CD and Fleckenstein, JL and Witt, TN and et al. (1993) Muscular ultrasound in idiopathic inflammatory myopathies of adults J Neurol Sci, 116, pp. 82-92.
42. Heckmatt, JZ and Dubowitz, V. (1988) Real-time ultrasound imaging of muscles Muscle Nerve, 11, pp. 56-65.
43. Stonecipher, MR and Jorizzo, JL and Monu, J and et al. (1994) Dermatomyositis with normal muscle enzyme concentrations. A single-blind study of the diagnostic value of magnetic resonance imaging and ultrasound Arch Dermatol, 130, pp. 1294-1299.
44. Pilkington, C and Owen, NJ and Bose, S and et al. (2000) A preliminary comparative study of high frequency muscle ultrasound and magnetic resonance imaging in 7 patients with juvenile dermatomyositis Ann Rheum Dis, 59, pp. 727-728.
45. Meng, C and Adler, R and Peterson, M and et al. (2001) Combined use of power Doppler and gray-scale sonography: A new technique for the assessment of inflammatory myopathy J Rheumatol, 28, pp. 1271-1282.
46. Feldman, BM and Rider, LG and Dugan, E and et al. (1999) Nailfold capillaries as indicators of disease activity in juvenile idiopathic inflammatory myopathies Arthritis Rheum, 42(Suppl.), pp. S664.
47. Pachman, LM and Mendez, E and Kanuru, R and et al. (1998) Nailfold capillary studies in 50 untreated children with juvenile dermatomyositis Arthritis Rheum, 41(Suppl.), pp. S265.
48. Scheja, A and Elborgh, R and Wildt, M. (1999) Decreased capillary density in juvenile dermatomyositis and in mixed connective tissue disease J Rheumatol, 26, pp. 1377-1381.
49. Szmidt-Salkowska, E and Rowinska-Marcinska, K and Lovelace, RE. (1989) EMG dynamics in polymyositis and dermatomyositis in adults Electromyogr Clin Neurophysiol, 29(7-8), pp. 399-404. Nov-Dec
50. Sandstedt, ER and Enriksson, KG and Larsson, LE. (1982) Quantitative electromyography in polymyositis and dermatomyositis Acta Neurol Scand, 65, pp. 110-121.
51. Johnsen, B and Fuglsang-Frederiksen, A and Vingtoft, S and et al. (1995) Inter- and intra-observer variation in the interpretation of electromyographic tests Electroencephalogr Clin Neurophysiol, 97, pp. 432-443.
52. Calore, EE and Cavaliere, MJ and Perez, NM. (1997) Muscle pathology in juvenile dermatomyositis Sao Paulo Med J, 115, pp. 1555-1559.
53. Dorph, C and Nennesmo, I and Lundberg, IE. (2001) Percutaneous conchotome muscle biopsy. A useful diagnostic and assessment tool J Rheumatol, 28, pp. 1591-1599.
54. Li, C and Varsani, H and Maillard, S and et al. (2004) Does histological features parallel clinical severity in juvenile dermatomyositis: Proposal of a novel scoring system Clin Exp Rheumatol, 22, pp. 529.
55. Miller, FW and Rider, LG and Chung, YL and et al. (2001) Proposed preliminary core set measures for disease outcome assessment in adult and juvenile idiopathic inflammatory myopathies Rheumatology, 40, pp. 1262-1273.
56. Ravelli, A and Duarte-Salazar, C and Buratti, S and et al. (2003) Assessment of damage in juvenile-onset systemic lupus erythematosus: A multicenter cohort study Arthritis Rheum, 49, pp. 501-507.
57. Ruperto, N and Buratti, S and Duarte-Salazar, C and et al. (2004) Health-related quality of life in juvenile-onset systemic lupus erythematosus and its relationship to disease activity and damage Arthritis Rheum, 51, pp. 458-464.
58. Gladman, D and Ginzler, E and Goldsmith, C and et al. (1996) The development and initial validation of the systemic lupus international collaborating clinics/American college of rheumatology damage index for systemic lupus erythematosus Arthritis Rheum, 39, pp. 363-369.
59. Ravelli, A and Ruperto, N and Martini, A. Outcome in juvenile onset systemic lupus erythematosus Curr Opin Rheumatol. (in press)
60. Landgraf, JM and Abetz, L and Ware, JEJ. (1996) The CHQ user's manual 1st ed. Boston, MA: The Health Institute, New England Medical Center.
61. Duffy, CM and Arsenault, L and Duffy, KN and et al. (1997) The juvenile arthritis quality of life questionnaire-development of a new responsive index for juvenile rheumatoid arthritis and juvenile spondyloarthritides J Rheumatol, 24, pp. 738-746.
62. Varni, JW and Seid, M and Smith Knight, T and et al. (2002) The pedsQL in pediatric rheumatology: Reliability, validity and responsiveness of the pediatric quality of life inventory generic core scales and rheumatology module Arthritis Rheum, 46, pp. 714-725.
63. Ruperto, N and Woo, P and Cuttica, R and et al. (2004) The validated PRINTO core set and definition of improvement for juvenile myositis Arthritis Rheum, 50(Suppl.), pp. S534.
64. Ruperto, N and Martini, A. (2004) International research networks in pediatric rheumatology: The PRINTO perspective Curr Opin Rheumatol, 16, pp. 566-570.
65. Ruperto, N and Ravelli, A and Murray, KJ and Lovell, DJ and Andersson-Gare, B and Feldman, BM and et al. (2003) Preliminary core sets of measures for disease activity and damage assessment in juvenile systemic lupus erythematosus and juvenile dermatomyositis Rheumatology (Oxford), 42(12), pp. 1452-1459.
66. Rider, LG and Giannini, EH and Brunner, HI and et al. (2004) International consensus on preliminary definitions of improvement in adult and juvenile myositis Arthritis Rheum, 50, pp. 2281-2290.